Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers

StatusActive
Effective start/end date16/08/1831/12/19

Funding

  • Sanofi Pasteur, Inc.: $58,255.00

Keywords

  • Biotechnology & Drug Development, Immunology